Once on the target page, be sure to click the Appl No link to access the data.

Main Page for USPTO Patents Patent/Exclusivity data file Federal Register pages Preferred API Supplier (Clients Only) Pharmacopeial Information

FDA Approval Activities for this Drug… Imodium Advanced (Loperamide HCl and Simethicone) Caplet McNeil Consumer Healthcare NDA 21-140 11/29/00 12/12/01 12/12/01 12/12/01 Imodium A-D Caplets McNeil Consumer Healthcare NDA 19860/S-018 Loperamide Hydrochloride & Simethicone Chewable Tablets, 2 mg/125 mg, OTC L. Perrigo Company ANDA 76-029 8/30/02 Loperamide Hydrochloride Tablets USP, 2 mg LNK International ANDA 76-497 6/10/03 Loperamide Hydrochloride Tablets USP, 2 mg L. Perrigo Company ANDA 75-232 LOPERAMIDE HYDROCHLORIDE Capsule; 2MG LOPERAMIDE HCL Geneva 017694 LOPERAMIDE HYDROCHLORIDE Capsule; 2MG IMODIUM MCNEIL CONS SPECLT 072741 LOPERAMIDE HYDROCHLORIDE Capsule; 2MG LOPERAMIDE HCL Mylan 073122 LOPERAMIDE HYDROCHLORIDE Capsule; 2MG LOPERAMIDE HCL Teva 073192 LOPERAMIDE HYDROCHLORIDE Capsule; 2MG LOPERAMIDE HCL Teva Imodium (loperamide HCL/simethicone) Caplets, McNeil Consumer Imodium A-D (loperamide HCL) Liquid, McNeil Consumer Imodium Advanced (loperamide HCL/simethicone) Caplets, McNeil Consumer Imodium Advanced (loperamide HCL/simethicone) Chewable Tablets, McNeil Consumer Imodium A-D (loperamide HCL) Liquid, McNeil Consumer, Formulation Revision For the latest approval information, please locate this active using the API Index.

Browse other API's patent/exclusivity pages… A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U-Z Patent Exclusivity Home | DMF Index | Search | Pharma Industry Portals | Site Map © 2009 Betterchem.com